Authors
Latest:
Dylan Essner on Documentation Tools for CAR T-Cell TherapyDylan Essner discussed the implementation of documentation tools and CRS, ICANS and ICE flow sheets within CAR T-cell therapy.
Latest:
Mark Schroeder, MD, Discusses Treatment Options for Acute GvHDMark Schroeder, MD, detailed 3 different potential treatments for acute graft versus host disease.
Latest:
Madan Jagasia, MBBS, MS, on Ruxolitinib to Treat Steroid Refractory GvHDMadan Jagasia, MBBS, MS, of the Vanderbilt University Medical Center discussed the next steps in treating acute graft versus host disease with ruxolitinib.
Latest:
Kevin Hughes, MD, on Breast Cancer Treatment Moving ForwardThe breast cancer expert spoke about decreasing the amount of treatment to receive the same impact for patients with breast cancer.
Latest:
Hope S. Rugo, MD, Talks Aromatase Inhibitors Plus Ribociclib in HR+/HER2– Advanced Breast CancerHope S. Rugo, MD, FASCO, gave an overview of ribociclib plus aromatase inhibitor use vs abemaciclib plus aromatase inhibitors for patients with hormone receptor-positive, HER2-negative advanced breast cancer.
Latest:
Patricia Jakel, RN, MN, AOCN, On Treating Patients with CDK 4/6 InhibitorsThe clinical nurse specialist was also diagnosed with stage III invasive lobular breast cancer and was treated with CDK 4/6 inhibitors, giving her the unique opportunity to speak to both the patient and clinical perspective.
Latest:
The Relationship Between Checkpoint Inhibitors and the Gut Microbiome and Its Application in Prostate CancerThis review article discusses the concepts of a tumor microenvironment and a gut microbiome and their effects on responses to checkpoint inhibitors (CPIs). It also reviews recent research investigating these 3 topics, and how it can be applied to using CPIs in prostate cancer.
Latest:
The Relationship Between Checkpoint Inhibitors and the Gut Microbiome and Its Application in Prostate CancerThis review article discusses the concepts of a tumor microenvironment and a gut microbiome and their effects on responses to checkpoint inhibitors (CPIs). It also reviews recent research investigating these 3 topics, and how it can be applied to using CPIs in prostate cancer.
Latest:
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline ReviewTwo case reports and a review of PCP in patients with solid tumors.
Latest:
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline ReviewTwo case reports and a review of PCP in patients with solid tumors.
Latest:
Pneumocystis jirovecii Pneumonia in Patients With Metastatic Prostate Cancer on Corticosteroids for Malignant Spinal Cord Compression: Two Case Reports and a Guideline ReviewTwo case reports and a review of PCP in patients with solid tumors.
Latest:
Hepatocellular Carcinoma Recurrence After Liver TransplantationThe case of a 64-year-old white woman with hepatitis C virus infection-related well-compensated cirrhosis with hepatocellular carcinoma recuurence.
Latest:
How to Radiologically Assess and Follow Response After Treatment of Hepatocellular CarcinomaA thought-provoking installment of Clinical Quandaries is presented by Alejandro Gabutti, MD; and Tommaso Cascella, MD, of a 36-year-old patient with hepatitis C virus-related cirrhosis and a subsequent diagnosis of hepatocellular carcinoma.
Latest:
Hepatocellular Carcinoma Recurrence After Liver TransplantationThe case of a 64-year-old white woman with hepatitis C virus infection-related well-compensated cirrhosis with hepatocellular carcinoma recuurence.
Latest:
Recurrent Small Cell Carcinoma of the Lung With Cutaneous Metastasis in BreastExperts present a case of recurrent small cell lung cancer presenting with a cutaneous metastatic nodule in the right breast.
Latest:
69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting AgentExperts discuss the case of a 69-year-old man with a history of metastatic prostate cancer previously treated with androgen deprivation therapy with leuprolide.
Latest:
69-Year-Old Man With Castration-Resistant Prostate Cancer Progressing After Docetaxel and Androgen Receptor-Targeting AgentExperts discuss the case of a 69-year-old man with a history of metastatic prostate cancer previously treated with androgen deprivation therapy with leuprolide.
Latest:
HPV and the Immune System in Head and Neck Cancers: Therapeutic ConsiderationsA review of the role of immune therapy in HPV-associated head and neck squamous cell carcinoma, along with the evidence and perspective behind differing therapeutic considerations.
Latest:
Chemotherapy Drug Shortages: It’s SolubleHoward S. Hochster, MD, reviews the potential solutions for the current chemotherapy drug shortages, and how this can be avoided in the future.
Latest:
MAIC Study Finds Similar Results With Linvoseltamab/Teclistamab in R/R Multiple MyelomaSimilar outcomes were noted when linvoseltamab and teclistamab were analyzed as treatments for patients with relapsed/refractory multiple myeloma.
Latest:
Defining PSA Nadir After Definitive Therapy in Prostate CancerBrian Helfand, MD, PhD, describes the ways in which the PSA nadir can be defined after definitive therapy and the implications of the definition used for patients with prostate cancer.
Latest:
Managing Prostate Cancer Surgical Patients during the COVID-19 Pandemic: A Brief Report of the Duke Cancer Institute’s Initial ExperienceExperts from the Duke Cancer Institute outline their current approach to stratifying surgical management of patients with prostate cancer.
Latest:
Immune-Related Adverse Events Involving Multiple Organ Sites in a Patient Treated With Nivolumab Plus IpilimumabExperts discuss the case of a 56-year-old white man who presents with multiple immune-related adverse events
Latest:
Association of Financial Conflicts of Interest With Academic Productivity Among Junior Faculty in Hematology and OncologyConflicts of interest for junior faculty members were evaluated at top cancer centers by Suneel D. Kamath, MD, et al. to determine how financial conflicts of interest correlated with measures of academic career productivity.
Latest:
Sotorasib Demonstrates Promising Antitumor Activity in Advanced NSCLCSotorasib showed promising antitumor activity in patients with non-small cell lung cancer that harbor the KRAS p.G12C mutation.
Latest:
FDA OKs Zanubrutinib to Treat Leukemia SubtypesPatients with chronic lymphocytic leukemia and small lymphocytic leukemia can now receive treatment with zanubrutinib following its approval by the FDA.
Latest:
Mirvetuximab Yields HRQOL Improvement in FRα-Positive Ovarian CancerPatient reported outcomes from the phase 3 MIRASOL trial showed improvement when mirvetuximab was used vs standard of care in folate receptor-alpha positive ovarian cancer resistant ovarian cancer.
Latest:
Stephen Schuster, MD, Gives Advice for Treating Aggressive Lymphomas During COVID-19 PandemicStephen Schuster, MD, talked about the benefits of conducting routine visits remotely during the COVID-19 pandemic, allowing doctors to see and treat more patients safely and efficiently.
Latest:
Greater Sleep Disturbance Associated With External Factors in Patients With GI CancersIn patients with gastrointestinal cancers, factors such as younger age and comorbidities, among others, were significantly associated with a greater likelihood of sleep disturbance.
